opc 12759 has been researched along with metallothionein in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukumoto, K; Handa, O; Harusato, A; Horie, R; Ichikawa, H; Inoue, K; Mizushima, K; Naito, Y; Takagi, T; Uchiyama, K; Yagi, N; Yamada, S; Yoshikawa, T | 1 |
1 other study(ies) available for opc 12759 and metallothionein
Article | Year |
---|---|
Rebamipide ameliorates indomethacin-induced small intestinal injury in rats via the inhibition of matrix metalloproteinases activity.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemokines; Down-Regulation; Indomethacin; Injections, Subcutaneous; Intestinal Mucosa; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Metallothionein; Quinolones; Rats; Rats, Wistar; Up-Regulation | 2012 |